Ozempic users may be making a major weight-loss mistake, new study suggests
Recent research reveals that individuals using GLP-1 weight-loss medications exhibit a decline in physical activity levels.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
📍 How it ended
Researchers reported that individuals using GLP-1 weight-loss drugs engaged in less physical activity, raising concerns about a potential decrease in muscle mass. The story quieted without a definitive conclusion in the coverage after reports highlighted the importance of exercise in maintaining the long-term value of the medication.
Epilogue added 146d ago, after coverage quieted.
The brief
New research indicates that patients prescribed GLP-1 medications, such as Ozempic, are engaging in less physical activity after beginning treatment. Investigators had initially hypothesized that weight loss facilitated by these drugs would encourage users to become more active, but findings suggest the opposite trend.
Coverage from outlets including Global News, New York Post, CBS News, and SciTechDaily emphasizes concerns regarding potential muscle mass loss associated with this reduction in activity. UVa researchers are cited as a primary source for the data regarding the risks to muscle tissue.
Future reports may clarify the long-term physiological impact of this reduced activity. Coverage does not yet specify if clinical guidelines will be updated to address exercise protocols for patients on these medications.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 146d ago.
Quick answers
What is the primary finding of the study?
The research indicates that individuals using GLP-1 drugs for weight loss tend to decrease their physical activity levels.
Are there concerns about muscle health?
Yes, UVa researchers warn that the decline in exercise among these users may lead to a decrease in muscle mass.
Did researchers expect these results?
No, researchers originally anticipated that weight loss from the drugs would result in an increase in physical activity.
Coverage (9)
- People on GLP-1 drugs appear to do less physical activity: study Global News · 150d ago
- GLP-1 users may be making a major weight-loss mistake, new study suggests New York Post · 150d ago
- UVa researchers warn weight loss drugs could decrease muscle mass WVTF · 150d ago
- Exercise boosts long-term value of GLP-1 drugs, study finds Benefits and Pensions Monitor · 150d ago
- Researchers Expected Ozempic Weight Loss to Boost Exercise. It Didn’t SciTechDaily · 150d ago
- Ozempic users may be making a major weight-loss mistake, new study suggests AOL.com · 150d ago
- People Cut Back on Physical Activity Once They Start GLP-1s for Obesity, Research Says People.com · 150d ago
- Losing weight with a GLP-1? Here's how to preserve your muscle mass. CBS News · 150d ago
- Ozempic users may be making a major weight-loss mistake, new study suggests Fox News · 150d ago
Topics
Related trends
Second child dies from measles in Grant County
Wisconsin health officials reported the second child death linked to measles in the state, with the child living in Grant County.
Measles cases nationwide top 5,400 as outbreaks spread across the US
The United States has lost its measles elimination status after 26 years following a historic resurgence that has sickened thousands.
Measles exposure may have occurred at 3 N.J. locations, including convention
New Jersey health officials warn of potential measles exposure at three Morris County locations after a non-resident attended LegionsCon while infectious last weekend.
Strokes are happening younger; reasons and risk factors, including possible link to cannabis use
Coverage from six outlets reports that strokes and TIAs are rising among adults under 55, with possible links to cannabis use under discussion.
DJ Khaled reflects on using GLP-1s in 90-pound weight loss journey: ‘I needed help’
DJ Khaled publicly details a 75-to-90-pound weight loss aided by GLP-1 medication Wegovy, sparking wide entertainment-media coverage.
Stronger flu shot linked to nearly 55% lower Alzheimer's risk
New research covering nearly 200,000 adults links high-dose influenza vaccination to a 55% reduction in Alzheimer's disease risk, sparking debate over correlation versus causation.